{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:23:09Z","timestamp":1790360589766,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T00:00:00Z","timestamp":1633737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00415-021-10838-6","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T07:18:02Z","timestamp":1633850282000},"page":"1825-1833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Intravenous thrombolysis in patients with central retinal artery occlusion: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"269","author":[{"given":"Lele","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4833-3536","authenticated-orcid":false,"given":"Ruijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"10838_CR1","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","volume":"72","author":"M Schrag","year":"2015","unstructured":"Schrag M, Youn T, Schindler J, Kirshner H, Greer D (2015) Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis. JAMA Neurol 72:1148\u20131154","journal-title":"JAMA Neurol"},{"key":"10838_CR2","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ophtha.2019.09.028","volume":"127","author":"CJ Flaxel","year":"2020","unstructured":"Flaxel CJ, Adelman RA, Bailey ST et al (2020) Retinal and ophthalmic artery occlusions preferred practice pattern\u00ae. Ophthalmology 127:259\u2013287","journal-title":"Ophthalmology"},{"issue":"10","key":"10838_CR3","doi-asserted-by":"publisher","first-page":"e041104","DOI":"10.1136\/bmjopen-2020-041104","volume":"24","author":"A Kido","year":"2020","unstructured":"Kido A, Tamura H, Ikeda HO, Miyake M, Hiragi S, Tsujikawa A (2020) Nationwide incidence of central retinal artery occlusion in Japan: an exploratory descriptive study using the National Database of Health Insurance Claims (2011\u20132015). BMJ Open 24(10):e041104","journal-title":"BMJ Open"},{"key":"10838_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14369","author":"J Pick","year":"2020","unstructured":"Pick J, Nickels S, Saalmann F, Finger RP, Schuster AK (2020) Incidence of retinal artery occlusion in Germany. Acta Ophthalmol. https:\/\/doi.org\/10.1111\/aos.14369 (Epub ahead of print)","journal-title":"Acta Ophthalmol"},{"key":"10838_CR5","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/eye.2013.25","volume":"27","author":"DD Varma","year":"2013","unstructured":"Varma DD, Cugati S, Lee AW, Chen CS (2013) A review of central retinal artery occlusion: clinical presentation and management. Eye 27:688\u2013697","journal-title":"Eye"},{"key":"10838_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.ophtha.2010.03.061","volume":"117","author":"M Schumacher","year":"2010","unstructured":"Schumacher M, Schmidt D, Jurklies B et al (2010) Central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment, a multicenter randomized trial. Ophthalmology 117:1367\u20131375","journal-title":"Ophthalmology"},{"key":"10838_CR7","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T et al (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 50:e344\u2013e418","journal-title":"Stroke"},{"key":"10838_CR8","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","volume":"44","author":"RL Sacco","year":"2013","unstructured":"Sacco RL, Kasner SE, Broderick JP et al (2013) An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 44:2064\u20132089","journal-title":"Stroke"},{"key":"10838_CR9","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1097\/SCS.0000000000007134","volume":"32","author":"X Wang","year":"2021","unstructured":"Wang X, Liu Y, Suo Y et al (2021) Intravenous recombinant tissue-type plasminogen activator thrombolysis for acute central retinal artery occlusion. J Craniofac Surg 32:313\u2013316","journal-title":"J Craniofac Surg"},{"key":"10838_CR10","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1161\/STROKEAHA.119.028743","volume":"51","author":"B Mac Grory","year":"2020","unstructured":"Mac Grory B, Nackenoff A, Poli S et al (2020) Intravenous fibrinolysis for central retinal artery occlusion: a cohort study and updated patient-level meta-analysis. Stroke 51:2018\u20132025","journal-title":"Stroke"},{"key":"10838_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12886-018-0768-4","volume":"18","author":"S Tobalem","year":"2018","unstructured":"Tobalem S, Schutz JS, Chronopoulos A (2018) Central retinal artery occlusion\u2014rethinking retinal survival time. BMC Ophthalmol 18:101","journal-title":"BMC Ophthalmol"},{"key":"10838_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.oret.2019.05.014","volume":"3","author":"M Jusufovic","year":"2019","unstructured":"Jusufovic M, Elsais A, Kerty E (2019) Seven points that explain the lack of effect from reperfusion therapy in central retinal artery occlusion. Ophthalmol Retina 3:713\u2013715","journal-title":"Ophthalmol Retina"},{"key":"10838_CR13","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"350","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647","journal-title":"BMJ"},{"key":"10838_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","volume":"25","author":"A Stang","year":"2010","unstructured":"Stang A (2010) Critical evaluation of the Newcastle\u2013Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603\u2013605","journal-title":"Eur J Epidemiol"},{"key":"10838_CR15","unstructured":"Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, www.cochrane-handbook.org"},{"key":"10838_CR16","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1001\/archopht.120.9.1234","volume":"120","author":"JC Kattah","year":"2002","unstructured":"Kattah JC, Wang DZ, Reddy C (2002) Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion. Arch Ophthalmol 120:1234\u20131236","journal-title":"Arch Ophthalmol"},{"key":"10838_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.ajo.2008.06.016","volume":"146","author":"LO Hattenbach","year":"2008","unstructured":"Hattenbach LO, Kuhli-Hattenbach C, Scharrer I, Baatz H (2008) Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion. Am J Ophthalmol 146:700\u2013706","journal-title":"Am J Ophthalmol"},{"key":"10838_CR18","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1161\/STROKEAHA.111.613653","volume":"42","author":"CS Chen","year":"2011","unstructured":"Chen CS, Lee AW, Campbell B et al (2011) Efficacy of intravenous tissue-type plasminogen activator in central retinal artery occlusion: report from a randomized, controlled trial. Stroke 42:2229\u20132234","journal-title":"Stroke"},{"key":"10838_CR19","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1161\/STROKEAHA.115.009839","volume":"46","author":"M Nedelmann","year":"2015","unstructured":"Nedelmann M, Graef M, Weinand F et al (2015) Retrobulbar spot sign predicts thrombolytic treatment effects and etiology in central retinal artery occlusion. Stroke 46:2322\u20132324","journal-title":"Stroke"},{"key":"10838_CR20","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.3892\/etm.2016.3681","volume":"12","author":"XJ Wu","year":"2016","unstructured":"Wu XJ, Gao F, Liu X, Zhao Q (2016) Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion. Exp Ther Med 12:2617\u20132621","journal-title":"Exp Ther Med"},{"key":"10838_CR21","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1177\/1747493016687578","volume":"12","author":"C Pr\u00e9terre","year":"2017","unstructured":"Pr\u00e9terre C, Godeneche G, Vandamme X et al (2017) Management of acute central retinal artery occlusion: Intravenous thrombolysis is feasible and safe. Int J Stroke 12:720\u2013723","journal-title":"Int J Stroke"},{"key":"10838_CR22","doi-asserted-by":"publisher","first-page":"e0198114","DOI":"10.1371\/journal.pone.0198114","volume":"13","author":"M Schultheiss","year":"2018","unstructured":"Schultheiss M, H\u00e4rtig F, Spitzer MS et al (2018) Intravenous thrombolysis in acute central retinal artery occlusion\u2014a prospective interventional case series. PLoS ONE 13:e0198114","journal-title":"PLoS ONE"},{"key":"10838_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren N, Ahmed N, D\u00e1valos A et al (2007) Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 369:275\u2013282","journal-title":"Lancet"},{"key":"10838_CR24","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa0804656","volume":"359","author":"W Hacke","year":"2008","unstructured":"Hacke W, Kaste M, Bluhmki E et al (2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359:1317\u20131329","journal-title":"N Engl J Med"},{"key":"10838_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/STROKEAHA.119.027478","volume":"51","author":"B Mac Grory","year":"2020","unstructured":"Mac Grory B, Lavin P, Kirshner H, Schrag M (2020) Thrombolytic therapy for acute central retinal artery occlusion. Stroke 51:687\u2013695","journal-title":"Stroke"},{"key":"10838_CR26","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1177\/112067211002000603","volume":"20","author":"AK Rudkin","year":"2010","unstructured":"Rudkin AK, Lee AW, Chen CS (2010) Ocular neovascularization following central retinal artery occlusion: prevalence and timing of onset. Eur J Ophthalmol 20:1042\u20131046","journal-title":"Eur J Ophthalmol"},{"key":"10838_CR27","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2147\/OPTH.S82796","volume":"9","author":"JO Mason 3rd","year":"2015","unstructured":"Mason JO 3rd, Patel SA, Feist RM et al (2015) Ocular neovascularization in eyes with a central retinal artery occlusion or a branch retinal artery occlusion. Clin Ophthalmol 9:995\u20131000","journal-title":"Clin Ophthalmol"},{"key":"10838_CR28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.3341\/kjo.2016.30.5.352","volume":"30","author":"YH Jung","year":"2016","unstructured":"Jung YH, Ahn SJ, Hong JH et al (2016) Incidence and Clinical Features of Neovascularization of the Iris following Acute Central Retinal Artery Occlusion. Korean J Ophthalmol 30:352\u2013359","journal-title":"Korean J Ophthalmol"},{"key":"10838_CR29","doi-asserted-by":"publisher","unstructured":"Schultheiss M, Spitzer MS, Hattenbach LO, Poli S (2021) Update intraven\u00f6se Lysetherapie : Die REVISION-Studie [Update on intravenous lysis treatment : The REVISION trial]. Ophthalmologe. German. https:\/\/doi.org\/10.1007\/s00347-021-01467-5.","DOI":"10.1007\/s00347-021-01467-5"},{"key":"10838_CR30","doi-asserted-by":"publisher","first-page":"5527292","DOI":"10.1155\/2021\/5527292","volume":"2021","author":"M Casagrande","year":"2021","unstructured":"Casagrande M, Kromer R, Wenzel DA et al (2021) Determination of ischemia onset based on automatically generated Spectralis SD-OCT values in acute central retinal artery occlusion. J Ophthalmol 2021:5527292","journal-title":"J Ophthalmol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10838-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10838-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T16:13:29Z","timestamp":1647965609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10838-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,9]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["10838"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10838-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,9]]},"assertion":[{"value":"11 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest or no disclosures relevant to the manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}